BH.IMMUN&BIO | SMS LIFESCIENCES INDIA | BH.IMMUN&BIO/ SMS LIFESCIENCES INDIA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -7.7 | 103.1 | - | View Chart |
P/BV | x | 1.5 | 1.2 | 125.3% | View Chart |
Dividend Yield | % | 0.0 | 0.2 | - |
BH.IMMUN&BIO SMS LIFESCIENCES INDIA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
BH.IMMUN&BIO Mar-23 |
SMS LIFESCIENCES INDIA Mar-23 |
BH.IMMUN&BIO/ SMS LIFESCIENCES INDIA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 52 | 948 | 5.5% | |
Low | Rs | 21 | 501 | 4.1% | |
Sales per share (Unadj.) | Rs | 10.3 | 903.8 | 1.1% | |
Earnings per share (Unadj.) | Rs | -3.9 | 37.7 | -10.2% | |
Cash flow per share (Unadj.) | Rs | -3.8 | 73.4 | -5.2% | |
Dividends per share (Unadj.) | Rs | 0 | 1.50 | 0.0% | |
Avg Dividend yield | % | 0 | 0.2 | 0.0% | |
Book value per share (Unadj.) | Rs | 20.4 | 558.3 | 3.7% | |
Shares outstanding (eoy) | m | 43.18 | 3.02 | 1,429.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 3.5 | 0.8 | 436.1% | |
Avg P/E ratio | x | -9.4 | 19.2 | -48.7% | |
P/CF ratio (eoy) | x | -9.5 | 9.9 | -96.1% | |
Price / Book Value ratio | x | 1.8 | 1.3 | 136.2% | |
Dividend payout | % | 0 | 4.0 | -0.0% | |
Avg Mkt Cap | Rs m | 1,561 | 2,190 | 71.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 151 | 434 | 34.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 446 | 2,730 | 16.3% | |
Other income | Rs m | 11 | 31 | 34.5% | |
Total revenues | Rs m | 457 | 2,760 | 16.5% | |
Gross profit | Rs m | -161 | 312 | -51.5% | |
Depreciation | Rs m | 2 | 108 | 1.9% | |
Interest | Rs m | 71 | 69 | 102.8% | |
Profit before tax | Rs m | -223 | 166 | -134.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | -56 | 52 | -107.9% | |
Profit after tax | Rs m | -166 | 114 | -146.3% | |
Gross profit margin | % | -36.0 | 11.4 | -315.4% | |
Effective tax rate | % | 25.3 | 31.4 | 80.4% | |
Net profit margin | % | -37.3 | 4.2 | -894.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 358 | 1,626 | 22.0% | |
Current liabilities | Rs m | 940 | 1,371 | 68.6% | |
Net working cap to sales | % | -130.6 | 9.4 | -1,394.6% | |
Current ratio | x | 0.4 | 1.2 | 32.1% | |
Inventory Days | Days | 85 | 9 | 973.6% | |
Debtors Days | Days | 1,135 | 616 | 184.3% | |
Net fixed assets | Rs m | 1,262 | 2,358 | 53.5% | |
Share capital | Rs m | 432 | 30 | 1,428.4% | |
"Free" reserves | Rs m | 450 | 1,656 | 27.2% | |
Net worth | Rs m | 882 | 1,686 | 52.3% | |
Long term debt | Rs m | 0 | 549 | 0.0% | |
Total assets | Rs m | 1,620 | 3,984 | 40.7% | |
Interest coverage | x | -2.2 | 3.4 | -63.0% | |
Debt to equity ratio | x | 0 | 0.3 | 0.0% | |
Sales to assets ratio | x | 0.3 | 0.7 | 40.2% | |
Return on assets | % | -5.9 | 4.6 | -129.1% | |
Return on equity | % | -18.9 | 6.7 | -279.5% | |
Return on capital | % | -17.2 | 10.5 | -164.3% | |
Exports to sales | % | 0 | 36.5 | 0.0% | |
Imports to sales | % | 14.5 | 26.4 | 54.8% | |
Exports (fob) | Rs m | NA | 998 | 0.0% | |
Imports (cif) | Rs m | 65 | 720 | 9.0% | |
Fx inflow | Rs m | 0 | 998 | 0.0% | |
Fx outflow | Rs m | 65 | 724 | 8.9% | |
Net fx | Rs m | -65 | 273 | -23.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 109 | 147 | 74.1% | |
From Investments | Rs m | 5 | -313 | -1.5% | |
From Financial Activity | Rs m | -147 | 169 | -87.1% | |
Net Cashflow | Rs m | -34 | 3 | -1,149.7% |
Indian Promoters | % | 59.3 | 71.2 | 83.2% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 40.8 | 28.8 | 141.4% | |
Shareholders | 35,313 | 8,116 | 435.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare BH.IMMUN&BIO With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | BH.IMMUN&BIO | SMS LIFESCIENCES INDIA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -2.23% | -2.55% | 0.31% |
1-Month | -2.23% | 0.71% | 0.08% |
1-Year | 28.97% | 20.75% | 54.11% |
3-Year CAGR | -13.27% | 4.32% | 14.46% |
5-Year CAGR | 30.36% | 4.53% | 20.04% |
* Compound Annual Growth Rate
Here are more details on the BH.IMMUN&BIO share price and the SMS LIFESCIENCES INDIA share price.
Moving on to shareholding structures...
The promoters of BH.IMMUN&BIO hold a 59.3% stake in the company. In case of SMS LIFESCIENCES INDIA the stake stands at 71.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BH.IMMUN&BIO and the shareholding pattern of SMS LIFESCIENCES INDIA.
Finally, a word on dividends...
In the most recent financial year, BH.IMMUN&BIO paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
SMS LIFESCIENCES INDIA paid Rs 1.5, and its dividend payout ratio stood at 4.0%.
You may visit here to review the dividend history of BH.IMMUN&BIO, and the dividend history of SMS LIFESCIENCES INDIA.
For a sector overview, read our pharmaceuticals sector report.
Indian share markets continued the momentum as the session progressed and ended higher.